Colton antigen system
Colton antigen system is a blood group system associated with the Aquaporin-1 (AQP1) protein, which is a water channel protein found in the red blood cell membrane. The Colton antigen system is named after the patient in whom the first antibody was identified.
History[edit]
The Colton antigen system was first described in 1953 by Landsteiner and Levine, who discovered an antibody in the serum of a patient named Colton. This antibody was found to react with all red blood cells except those of the patient and his family, leading to the identification of a new blood group system.
Genetics[edit]
The Colton antigen system is encoded by the AQP1 gene located on chromosome 7. This gene encodes the Aquaporin-1 protein, which forms a water channel in the red blood cell membrane. There are three known alleles in the Colton system: Co(a), Co(b), and Co3. The Co(a) and Co(b) antigens are determined by a single amino acid substitution at position 45 of the AQP1 protein.
Clinical significance[edit]
The Colton antigen system is clinically significant in blood transfusion and pregnancy. Antibodies to the Colton antigens can cause hemolytic transfusion reaction and hemolytic disease of the fetus and newborn (HDFN). However, these reactions are rare because anti-Co(a) and anti-Co(b) are usually not clinically significant, and the Co3 antigen is high frequency, meaning it is present in most individuals.
See also[edit]
References[edit]
This blood group related article is a stub. You can help WikiMD by expanding it.
Colton antigen system[edit]
-
Serology interpretation of antibody panel for blood group antigens
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian